David Favre

Years Active: 2020-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Afam A Okoye, Remi Fromentin, Hiroshi Takata, Jessica H Brehm, Yoshinori Fukazawa, Bryan Randall, Marion Pardons, Vincent Tai, Jun Tang, Jeremy V Smedley, Michael K Axthelm, Jeffrey D Lifson, Louis J Picker, David Favre, Lydie Trautmann, Nicolas Chomont
The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription. PLoS pathogens 18 (1) (2022)
Justin L Harper, Shari Gordon, Chi Ngai Chan, Hong Wang, Emily Lindemuth, Cristin Galardi, Shane D Falcinelli, Samuel L M Raines, Jenna L Read, Kevin Nguyen, Colleen S McGary, Michael Nekorchuk, Kathleen Busman-Sahay, James Schawalder, Colin King, Maria Pino, Luca Micci, Barbara Cervasi, Sherrie Jean, Andrew Sanderson, Brian Johns, A Alicia Koblansky, Heather Amrine-Madsen, Jeffrey Lifson, David M Margolis, Guido Silvestri, Katharine J Bar, David Favre, Jacob D Estes, Mirko Paiardini
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption. Nature medicine 26 (4) (2020)

David Favre.css-eqlu8i{font-size:small;padding-left:4px;}